Equities

International Stem Cell Corp

ISCO:QBB

International Stem Cell Corp

Actions
  • Price (USD)0.0805
  • Today's Change0.00 / 0.00%
  • Shares traded1.35k
  • 1 Year change-42.50%
  • Beta0.2873
Data delayed at least 15 minutes, as of Jun 13 2024 18:16 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

International Stem Cell Corporation is a clinical-stage biotechnology company that is focused on therapeutic and biomedical product development. The Company is primarily a research and development company, for the therapeutic market, which has focused on advancing potential clinical applications of human parthenogenetic stem cells (hpSCs) for the treatment of various diseases of the central nervous system and liver diseases. The Company's products are based on human cell culture and a type of pluripotent stem cells and hpSCs. The Company's subsidiaries include Lifeline Cell Technology, LLC (LCT), which develops, manufactures and commercializes primary human cell research products for the biomedical market; Lifeline Skin Care, Inc. (LSC), which develops, manufactures and markets a category of anti-aging skin care products for anti-aging market, and Cyto Therapeutics Pty. Ltd. (Cyto Therapeutics) performs research and development (R&D) for the therapeutic market.

  • Revenue in USD (TTM)7.83m
  • Net income in USD-327.00k
  • Incorporated2005
  • Employees29.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
NovAccess Global Inc0.00-1.74m546.38k1.00---------0.1193-0.11930.00-0.22460.00----0.00-1,836.30-2,185.89-------------------------177.93------
Pharmagreen Biotech Inc1.56k-500.66k597.28k0.00------382.87-0.0011-0.00110.00-0.00450.0094--3.35---302.10-472.20----11.54---32,096.15--0.0194-71.71--------80.68------
Molecular Pharmacology (USA) Ltd0.00-105.18k599.73k0.00---------0.0009-0.00090.00-0.01880.00-------976.60-1,219.29------------------------44.29------
Limitless X Holdings Inc14.21m-8.40m636.40k12.00------0.0448-2.10-2.103.58-3.513.731.7714.401,184,068.00-220.35------77.76---59.15--0.0173-9.02-----65.83---60.80------
Emo Capital Corp-100.00bn-100.00bn639.85k0.00---------------0.0017-----------7,495.00-------------------------138.44------
International Stem Cell Corp7.83m-327.00k644.35k29.00------0.0823-0.0409-0.04090.97850.00451.462.5311.87270,069.00-5.81-29.22-68.13-73.8258.5859.49-3.97-21.010.4672-6.060.9898---4.78-6.8260.42---34.45--
Capstone Holding Corp0.00-358.00k646.20k2.00---------6.58-38.120.00-60.700.00-------113.46141.94-199.60173.06-----------2.92--------52.46------
Bespoke Extracts Inc785.45k-1.48m647.74k10.00------0.8247-0.1458-0.14580.0774-0.16962.0655.9934.7378,545.00-388.21------43.69---188.79--0.0612-135.42----22,933.72--63.98------
Scisparc Ltd0.00-6.96m658.85k3.00--27.05-----1.22-1.510.000.03440.00----0.00-92.51-69.39-152.41-111.07-------527.17----0.9371--113.73---97.61------
CNS Pharmaceuticals Inc0.00-17.46m661.34k3.00---------179.17-179.170.00-20.760.00----0.00-384.86-132.47---185.75---------------------23.42------
Sativus Tech Corp0.00-68.00k695.57k-----------0.0483-0.04830.00-0.52380.00-------18.8325.48----------------5.41------78.78------
GlobeStar Therapeutics Corp0.00-1.98m697.75k-----------0.0023-0.00230.00-0.00150.00-------38,103.72-4,657.88-------7,790.20---2,834,410.00---21.00---------31.01------
Data as of Jun 13 2024. Currency figures normalised to International Stem Cell Corp's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.